Cambridge, Massachusetts-based Biogen Inc. (BIIB) discovers, develops, manufactures, and delivers therapies for treating ...

Eli Lilly (NYSE:LLY) has received regulatory approval to market its Alzheimer’s therapy Kisunla (donanemab) in Australia, ...

SNY inks an agreement to acquire VIGL and its pipeline candidate VG-3927, which is being developed to treat Alzheimer's ...

BIIB). The Australian Therapeutic Goods Administration (TGA) issued the marketing authorization for Kisunla to treat certain adults with mild cognitive impairment and mild dementia linked to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

This page offers a complete view of BIIB stock history, enabling you to study performance over specific time frames. Download data effortlessly for in-depth analysis and informed decision-making ...

As of May 16 at 2:20:29 PM EDT. Market Open.

US Europe Asia Rates Commodities Currencies Cryptocurrencies S&P 500 5,923.87-16.59 (-0.28%) ...

Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies are ...